Trajenta 5 mg Tablet is a trusted oral medication designed to manage type 2 diabetes mellitus in adults. Containing Linagliptin (5 mg) as its active ingredient, this tablet belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, which help regulate blood sugar levels effectively. Manufactured by Boehringer Ingelheim, a global leader in pharmaceuticals, Trajenta is used alongside a healthy diet and exercise to improve glycemic control, reducing the risk of diabetes-related complications like kidney damage, nerve issues, or vision loss. It’s a reliable choice for those seeking a convenient, once-daily solution to keep their diabetes in check.

Key Features

• Active Ingredient: Linagliptin (5 mg), a potent DPP-4 inhibitor.
• Purpose: Enhances blood sugar control in adults with type 2 diabetes when diet, exercise, or other treatments alone aren’t enough.
• Packaging: Available in a strip of 10 light red, round, film-coated tablets, debossed with “D5” on one side and the Boehringer Ingelheim logo on the other.
• Quality Assurance: Produced under strict Good Manufacturing Practices (GMP), ensuring safety, consistency, and efficacy.

Benefits

• Effective Glucose Control: Boosts insulin release and reduces glucagon levels when blood sugar is high, helping maintain stable levels without causing lows when glucose is normal.
• Flexible Use: Can be used alone or combined with other diabetes medications like metformin, sulfonylureas, or insulin for tailored treatment.
• Once-Daily Convenience: A single tablet fits seamlessly into busy lifestyles, supporting consistent adherence.
• Kidney-Friendly: Safe for patients with kidney issues no dose adjustment needed, unlike some other diabetes drugs.

How It Works
Trajenta’s Linagliptin works by inhibiting the DPP-4 enzyme, which breaks down incretin hormones. These hormones, released after meals, signal the pancreas to produce insulin and curb liver glucose output. By extending incretin activity, Trajenta enhances insulin release and lowers glucagon when blood sugar spikes, effectively controlling fasting and post-meal glucose levels. It’s glucose-dependent, meaning it won’t overcorrect and cause hypoglycemia when levels are normal.

Dosage and Administration

• Recommended Dose: One 5 mg tablet daily, taken orally with or without food, ideally at the same time each day for steady results.
• Instructions: Swallow whole with a glass of water—do not crush, chew, or split. Follow your doctor’s prescription precisely.
• Note: If you miss a dose, take it as soon as you remember unless it’s nearly time for the next one—don’t double up. Consult your doctor before stopping, as abrupt discontinuation may raise blood sugar.

Safety Information

• Side Effects: Generally well-tolerated, with mild effects like headache, sore throat, cough, or nasal congestion possible. Rare but serious issues such as pancreatitis (severe stomach pain), low blood sugar (when combined with other drugs), or allergic reactions (rash, swelling) require immediate medical attention.
• Precautions: Not for type 1 diabetes or diabetic ketoacidosis. Avoid if allergic to Linagliptin. Use cautiously with a history of pancreatitis, heart failure, or when combined with insulin/sulfonylureas (hypoglycemia risk). Limited data exists for pregnancy/breastfeeding consult your doctor.
• Storage: Store at 20-25°C (68-77°F), away from moisture, heat, and children’s reach.

Why Choose Trajenta 5 mg Tablet?
Trajenta 5 mg stands out for its simplicity, efficacy, and versatility. Its once-daily dosing, kidney-safe profile, and ability to pair with other treatments make it a go-to for managing type 2 diabetes. Backed by Boehringer Ingelheim’s expertise, it’s a cost-effective, science-driven option to help you live confidently while keeping glucose in check. Pair it with lifestyle changes, and you’re set for long-term health.